Page last updated: 2024-12-11
8-hydroxygeraniol
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
8-hydroxygeraniol: isolated from Cistanche tubulosa [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
(6E)-8-hydroxygeraniol : A monoterpenoid that is geraniol bearing a hydroxy substituent at position 8. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Related Flora
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|---|---|---|---|
| Cistanche | genus | A plant genus of the family OROBANCHACEAE. Members contain phenylethanoid glycosides.[MeSH] | Orobanchaceae | The broom-rape plant family of the order Lamiales.[MeSH] |
| Cistanche tubulosa | species | [no description available] | Orobanchaceae | The broom-rape plant family of the order Lamiales.[MeSH] |
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 5363397 |
| CHEBI ID | 64235 |
| SCHEMBL ID | 900304 |
| SCHEMBL ID | 900303 |
| MeSH ID | M0446283 |
Synonyms (24)
| Synonym |
|---|
| (e)-8-hydroxygeraniol |
| (6e)-8-hydroxygeraniol |
| trans,trans-2,6-dimethyl-2,6-octadiene-1,8-diol |
| 8-hydroxygeraniol |
| C17621 |
| 10-hydroxygeraniol |
| (2e,6e)-2,6-dimethylocta-2,6-diene-1,8-diol |
| 2,6-dimethyl-2,6-octadiene-1,8-diol, (2e,6e)- |
| unii-6wx29m860a |
| 2,6-octadiene-1,8-diol, 2,6-dimethyl-, (e,e)- |
| 6wx29m860a , |
| 26488-97-1 |
| CHEBI:64235 |
| SCHEMBL900304 |
| SCHEMBL900303 |
| (2e,6e)-2,6-dimethyl-2,6-octadiene-1,8-diol # |
| PREUOUJFXMCMSJ-TXFIJWAUSA-N |
| 2,6-octadiene-1,8-diol, 2,6-dimethyl-, (2e,6e)- |
| (e,e)-2,6-dimethyl-2,6-octadiene-1,8-diol |
| (e,e)-2,6-dimethylocta-2,6-diene-1,8-diol |
| Q20707312 |
| (2e,6e)-2,6-dimethyl-2,6-octadiene-1,8-diol |
| trans,trans-2,6-dimethyl-2,6-octadiene-1,8-diol) |
| AKOS040824553 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Drug Classes (3)
| Class | Description |
|---|---|
| monoterpenoid | Any terpenoid derived from a monoterpene. The term includes compounds in which the C10 skeleton of the parent monoterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups). |
| prenols | Any alcohol possessing the general formula H-[CH2C(Me)=CHCH2]nOH in which the carbon skeleton is composed of one or more isoprene units (biogenetic precursors of the isoprenoids). |
| diol | A compound that contains two hydroxy groups, generally assumed to be, but not necessarily, alcoholic. Aliphatic diols are also called glycols. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
Pathways (1)
| Pathway | Proteins | Compounds |
|---|---|---|
| secologanin and strictosidine biosynthesis | 3 | 32 |
| secologanin and strictosidine biosynthesis | 13 | 36 |
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 18.31
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (18.31) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||